Cancer Care Ontario | Action Cancer Ontario

olaparib - In combination with abiraterone, and prednisone or prednisolone for the treatment of metastatic castration resistant prostate cancer (mCRPC), based on criteria

ODB - General Benefit

prednisone

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Guidelines and Advice

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024

Amanda Sheppard

Senior Scientist, Indigenous Cancer Care Unit, Acute and Hospital-Based Care, Ontario Health Lead Scientist amanda.sheppard@ontariohealth.ca

Amanda Sheppard

Senior chercheuse, Unité des soins de cancérologie chez les peuples autochtones, Soins aigus et hospitaliers, Santé Ontario Chercheuse...

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

ABFM(INTERIM MNT)

Abridged-FAQs-for-providers-offering-colposcopy.pdf

Abridged-FAQs-for-providers-offering-colposcopy-FR.pdf

Abridged-FAQs-for-providers-offering-cervical-screening.pdf

Abridged-FAQs-for-providers-offering-cervical-screening-FR.pdf

AL-Referral-Information-Package.pdf

AL-Referral-Information-Package-FR.pdf

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

ABIROLAPPRED

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Amanda Sheppard

Amanda Sheppard

Pages